Navigation

Breast cancer (metastatic) -trastuzumab (as monotherapy and in combination with a taxane) [ID345]

Trastuzumab as monotherapy and in combination with a taxane for the treatment of metastatic breast cancer (to include a review of TA34).

Status: Suspended
Expected date of issue: October 2011
Process: MTA
Notes:

A scoping workshop was held in June 2010, where potential changes to the remit of this appraisal were proposed. These proposals were put the Department of Health, who are currently in the process of considering the request to amend the remit. There are a complex set of issues to be discussed regarding the suggested changes to the remit and these need to be explored further before the Department of Health can take a decision.

Therefore, this appraisal is now suspended and we will inform you of updated arrangement for this appraisal as soon as we can.

Topic area:
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Raisa Sidhu
Communications manager: Laura Gibson
Project manager: Rebecca Pye
Top


 

Provisional schedule

Consultation on draft scope by stakeholders: 24 March 2010
Information meeting with consultees: TBC
Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC
2nd appraisal committee meeting: TBC
Top


 

Consultees and commentators

To be confirmed

Top


 

Key documents

This page was last updated: 18 May 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.